Is EDSS Enough to Predict Risk of Upper Urinary Tract Damage in Patients with Multiple Sclerosis?
Expanded Disability Status Scale (EDSS)
multiple sclerosis (MS)
neurogenic lower urinary tract dysfunction (nLUTD)
retrospective study
urodynamic study
Journal
Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304
Informations de publication
Date de publication:
22 Nov 2022
22 Nov 2022
Historique:
received:
25
10
2022
revised:
15
11
2022
accepted:
16
11
2022
entrez:
23
12
2022
pubmed:
24
12
2022
medline:
24
12
2022
Statut:
epublish
Résumé
Lower urinary tract dysfunction is often observed in patients with multiple sclerosis (MS) and may be responsible for an increased risk of upper urinary tract (UUT) damage. Although there are well-known urodynamic risk factors for UUT damage, no clinical prediction parameters are clearly identified. We aimed to confirm the accuracy of the Expanded Disability Status Scale (EDSS) in predicting urodynamic risk factors for UUT deterioration and to assess other clinical parameters potentially predicting urodynamic risk factors. We retrospectively reviewed 201 patients with MS referred for primary neuro-urological work-up, including a video-urodynamic study (VUDS) from August 2009 to February 2020. Multivariate modeling revealed EDSS, male gender, and a number of LUTS as clinical parameters significantly associated with urodynamic risk factors for UUT damage (
Identifiants
pubmed: 36551757
pii: biomedicines10123001
doi: 10.3390/biomedicines10123001
pmc: PMC9775948
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Autoimmun Rev. 2014 Apr-May;13(4-5):518-24
pubmed: 24424194
Transl Androl Urol. 2016 Feb;5(1):31-8
pubmed: 26904410
Neurourol Urodyn. 2016 Jan;35(1):48-54
pubmed: 25327401
J Urol. 1981 Aug;126(2):205-9
pubmed: 7196460
Neurourol Urodyn. 1998;17(2):89-98
pubmed: 9514141
Neuroepidemiology. 2001 May;20(2):138-43
pubmed: 11359083
Neurology. 1983 Nov;33(11):1444-52
pubmed: 6685237
Postgrad Med J. 2009 Oct;85(1008):552-9
pubmed: 19789195
Mult Scler. 2013 Dec;19(14):1931-7
pubmed: 23698129
Neurol Sci. 2008 Dec;29 Suppl 4:S352-5
pubmed: 19089675
Neurourol Urodyn. 2015 Jan;34(1):32-6
pubmed: 24115110
World J Urol. 2013 Feb;31(1):229-33
pubmed: 22227822
Prog Urol. 2012 Dec;22(16):1026-32
pubmed: 23178100
Mult Scler. 2007 Aug;13(7):915-28
pubmed: 17881401
Arch Phys Med Rehabil. 1999 Apr;80(4):437-41
pubmed: 10206607
Int Urogynecol J. 2010 Jan;21(1):5-26
pubmed: 19937315
J Urol. 1995 Jul;154(1):169-73
pubmed: 7539859
Int Urol Nephrol. 2020 May;52(5):859-863
pubmed: 31983045
Neurourol Urodyn. 2014 Apr;33(4):370-9
pubmed: 24390971
Neurol Sci. 2011 Dec;32(6):1223-31
pubmed: 21948057
Urol Clin North Am. 2010 Nov;37(4):547-57
pubmed: 20955906
Brain. 2005 Nov;128(Pt 11):2705-12
pubmed: 16230320
Int J MS Care. 2020 Mar-Apr;22(2):91-99
pubmed: 32410904
J Urol. 1989 Jun;141(6):1390-3
pubmed: 2724437
Brain. 1980 Jun;103(2):281-300
pubmed: 7397479
J Urol. 1965 May;93:548-52
pubmed: 14290406
Mult Scler. 2018 Apr;24(4):529-534
pubmed: 28367674